Literature DB >> 29302697

[Laser and light therapy for treatment of radiation dermatitis].

H-J Laubach1, J Robijns2.   

Abstract

Radiation dermatitis (RD), an inflammatory skin disease that can be an unwanted side effect of medical radiation therapy (RT), most commonly occurs in patients undergoing cancer of the ENT, anal, and vulvar regions. The side effects on the skin and mucous membranes occur within a few weeks after the initiation of RT; however, late side effects can develop months to years after the RT. Therapeutically, various treatment approaches are considered such as pentoxifylline, hyperbaric oxygen therapy, laser therapy, and PBMT. In order to limit the reduced quality of life of patients with RT-induced fibrosis, supportive care consisting of pain therapy, psychological support, and wound care is necessary.

Entities:  

Keywords:  Aftercare; Quality of life; Radiotherapy; Side effects; Treatment

Mesh:

Year:  2018        PMID: 29302697     DOI: 10.1007/s00105-017-4091-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  35 in total

Review 1.  Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006.

Authors:  Sharon R Hymes; Eric A Strom; Caroline Fife
Journal:  J Am Acad Dermatol       Date:  2006-01       Impact factor: 11.527

Review 2.  Ionizing radiation: the good, the bad, and the ugly.

Authors:  Julie L Ryan
Journal:  J Invest Dermatol       Date:  2012-01-05       Impact factor: 8.551

Review 3.  Skin toxicity during breast irradiation: pathophysiology and management.

Authors:  Jennifer L Harper; Lynette E Franklin; Joseph M Jenrette; Eric G Aguero
Journal:  South Med J       Date:  2004-10       Impact factor: 0.954

4.  Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter.

Authors:  Geraldine Jacobson; Sudershan Bhatia; Brian J Smith; Anna M Button; Kellie Bodeker; John Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-28       Impact factor: 7.038

Review 5.  Introduction to radiotherapy and standard teletherapy techniques.

Authors:  Ehsan H Balagamwala; Abigail Stockham; Roger Macklis; Arun D Singh
Journal:  Dev Ophthalmol       Date:  2013-08-26

6.  Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages.

Authors:  L J Marques; L Zheng; N Poulakis; J Guzman; U Costabel
Journal:  Am J Respir Crit Care Med       Date:  1999-02       Impact factor: 21.405

7.  Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer.

Authors:  Lone Gothard; Anthony Stanton; Julie MacLaren; David Lawrence; Emma Hall; Peter Mortimer; Eileen Parkin; Joyce Pritchard; Jane Risdall; Robert Sawyer; Mary Woods; John Yarnold
Journal:  Radiother Oncol       Date:  2004-03       Impact factor: 6.280

Review 8.  The radiotherapeutic injury--a complex 'wound'.

Authors:  James W Denham; Martin Hauer-Jensen
Journal:  Radiother Oncol       Date:  2002-05       Impact factor: 6.280

9.  Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.

Authors:  Lone Gothard; Paul Cornes; Judith Earl; Emma Hall; Julie MacLaren; Peter Mortimer; John Peacock; Clare Peckitt; Mary Woods; John Yarnold
Journal:  Radiother Oncol       Date:  2004-11       Impact factor: 6.280

10.  Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition.

Authors:  Jessica Deree; Joilson O Martins; Heidi Melbostad; William H Loomis; Raul Coimbra
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.